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Abstract
Background: Hyperkalemia is a common complication of renal transplantation (RT). Normal saline (NS) remains the most com-
monly used infusion solution during RT to avoid hyperkalemia, but it is associated with hyperchloremic metabolic acidosis.
Objectives: We aimed to study the metabolic profile and renal function in RT patients managed with equal NS and ringer’s lactate
(RL) solution versus NS alone.
Methods: In this randomized controlled trial, 46 adult patients (17 females and 29 males) undergoing living-related RT were re-
cruited and divided into the two groups according to the IV fluid infusion: NS and RL-NS. Subsequently, patients were evaluated
based on arterial blood gas (ABG) test, sodium (Na), potassium (K), blood urea nitrogen (BUN), and creatinine (Cr) before and after
RT and 3 and 7-day BUN and Cr.
Results: The mean age of the patients was 44.52± 12.58 years in NS and 45.43± 14.29 years in NS-RL group. There were no significant
differences in the demographic and baseline patients’ characteristics between the two groups. BUN and Cr were lower in the NS
group up to 7 days after RT (all P < 0.05). Serum Na was lower in the NS-RL group and serum K was higher in this group significantly
(P = 0.004 and 0.028, respectively). No significant difference was observed regarding acid-base balance and other ABG measures. No
case of hyperkalemia or acidosis was observed after RT.
Conclusions: Our study showed that neither NS nor NS-RL solutions were associated with the risk of hyperkalemia or acidosis after
RT; however, renal function was superior in patients receiving the NS infusion.
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1. Background
The gold standard management of patients with end-
stage renal disease (ESRD) is renal transplantation (RT).
There is a concern to achieve the best possible outcome
following RT via established protective measures, includ-
ing hydrotherapy due to kidney donor shortage (1, 2). Pa-
tients undergoing RT are at risk of a variety of complica-
tions, which could influence the outcome of transplan-
tation (3). Maintaining optimal intravascular volume via
crystalloids administration is crucial to ensure early re-
nal perfusion and function in these patients (4, 5). Hyper-
kalemia is a common complication of RT which could oc-
cur in 25% - 40% of recipients. It could lead to significant
hemodynamic and neurological changes (6). To avoid this
condition, the choice of IV fluid for perioperative care has
recently received increasing attention (7). Classically, nor-
mal saline (NS) has been chosen during the perioperative
period RT. This choice has been based on the belief that
the use of potassium-containing replacement fluids such
as ringer’s lactate (RL) could produce hyperkalemia (8). A
survey of U.S. kidney transplant centers revealed that NS
and NS-based solutions are preferred IV fluids for the ad-
ministration during RT surgery (9).
However, several papers suggested that the usual need
for administration of large volumes of NS in patients un-
dergoing RT, is associated with hyperchloremic metabolic
acidosis (10), which may theoretically cause hyperkalemia
through an extracellular shift of potassium (K) ions (11).
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Furthermore, hyperchloremia may cause vasoconstriction
in renal arteries, which could result in decreased urine out-
put (12, 13). In addition, rapid administration of NS in pa-
tients with pre-existent metabolic acidosis can exacerbate
acid-base imbalances immediately after reperfusion of the
kidney (14).
This concept was the basis for the elaboration of sev-
eral studies during the last decade comparing the use of NS
and balanced crystalloid solutions (including potassium
in their formulation) during the perioperative period of
renal transplantation, which all declared that the develop-
ment of metabolic acidosis and hyperchloremia more fre-
quently occur via the NS infusion compared to the RL one
(3, 4, 7, 9, 15). Nevertheless, the NS remains the most com-
monly used infusion solution during RT (16).
2. Objectives
According to the evidence and shortcoming of NS infu-
sion in RT patients, it was hypothesized that an equal com-
bination of NS and RL could be effective in maintaining re-
nal function after RT; thus we designed a study compar-
ing the metabolic profile and renal function in RT patients
managed with NS-RL solution versus NS.
3. Methods
3.1. Study Design and Setting
This randomized clinical trial study was conducted
at the Hasheminejad Hospital in 2017 - 2018. This study
was approved by the Institutional Review Board and
the Ethics Committee (IR.IUMS.FMD.REC1396.9411174015)
of Iran University of Medical Sciences prior to patient
enrollment and written informed consent was obtained
from all participants. The trial was registered at irct.ir
(IRCT20170910036107N4, principal investigator: Mehrdad
Mesbah Kiaee, date of registration: 2019-04-10).
3.2. Participants
Forty-six adult patients of either gender, aged 18 - 70
years undergoing living donor RT due to ESRD were in-
cluded. Exclusion criteria were severe cardiovascular dis-
ease (ASA (American Society of Anesthesiology) III and IV),
preoperative hyperkalemia of > 5.5 mEq/L, using blood
transfusion during RT, metabolic acidosis with pH < 7.2,
dialysis after the surgery, the duration of the operation
more than four hours, and deceased donor RT.
3.3. Randomization, Patient’s Enrolment, and Blinding
Participants who enrolled in the study were randomly
classified (using block randomization method) into the 2
groups according to IV fluid infusion: patients in the NS
group (n = 23), receiving normal saline solution and those
in the NS-RL group (n = 23), receiving equal ringer’s lac-
tate and normal saline solution. The physicians responsi-
ble for the outcome measures, subjects, and data analysis
were blinded to the groups.
3.4. Anesthesia Induction and Renal Transplantation
Before the induction of anesthesia, an 18-gauge intra-
venous catheter was inserted in all patients for fluid and
drug infusion. A 20-gauge arterial catheter was also used
to obtain arterial blood samples during the operation. All
patients were pre-medicated with 2 µg/kg of fentanyl and
0.03 µg/kg of midazolam. Then general anesthesia was
induced by the injection 4 mg/kg of sodium thiopental
(16). The donor kidney was implanted in the right or left
retroperitoneal space of the recipient with vascular anas-
tomoses to the right or left external or internal iliac artery
and vein (9). During the surgery, every half an hour, an arte-
rial sample was taken in order to check for the occurrence
of severe metabolic acidosis and hyperkalemia.
Intra-operatively fluids were given based on the hemo-
dynamics to maintain systolic pressure variation (SPV) be-
tween 5 - 15 mmHg. Post-operative IV fluid infusion was the
same in all of the participants. At the end of the surgery,
the patients were reversed with 0.05 mg/kg of neostigmine
and 0.02 mg/kg of atropine (16).
3.5. Outcome Measures
Arterial blood samples were obtained to evaluate arte-
rial blood gas (ABG) test at baseline before anesthesia in-
duction and postoperatively for measurement of pH, par-
tial pressure of carbon dioxide (pCO2), bicarbonate (HCO3),
base excess of the extracellular fluid (BEesf ) and base ex-
cess (BE). Blood urea nitrogen (BUN), serum creatinine (Cr),
sodium (Na), and potassium (K) were also measured before
and after RT. The measurement of BUN and Cr was repeated
3 days (72 hours) and 7 days (168 hours) after the transplan-
tation. These outcome measures were used to compare the
effectiveness of the two infusion solutions.
3.6. Statistical Analysis
The SPSS statistics software V. 22 (SPSS Inc., Chicago,
USA) was used for statistical analysis. The normal distribu-
tion of the data was evaluated using Kolmogorov-Simonov
test. The parametric and non-parametric data were evalu-
ated by Independent Sample t-test and chi-square, respec-
tively. Repeated measures design was used to compare the
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variables over time. The significant threshold was consid-
ered to be less than 0.05.
4. Results
Forty-six patients were assessed for eligibility. All of
the patients met the inclusion criteria. They were divided
into two 23-member groups. No participant was lost in the
follow-up sessions or during analysis. Thus 23 patients in
the NS group and 23 patients in the NS-RL group were ana-
lyzed (Consort flow diagram).
4.1. Patient Demographics
As it is noted in Table 1, there were no significant dif-
ferences in the patients’ demographic and baseline char-
acteristics between the two groups (all with P > 0.05). The
mean age of the patients was 44.52 ± 12.58 years in the NS
group and 45.43 ± 14.29 years in the NS-RL group. More-
over, 17 of 46 patients were female (37%) and 29 were male
(63%). Of the patients in the NS group, 11 were female and
12 were male. In the NS-RL group, there were 6 female and
17 male patients. Patients’ baseline BUN and Cr were 39.22
± 29.74 mg/dL and 6.90 ± 3.73 mg/dL in the NS group and
29.74 ± 11.31 mg/dL and 6.25 ± 2.07 mg/dL in the NS-RL
group, respectively. Serum Na was 139.17 ± 2.77 mEq/L and
137.22 ± 3.15 mEq/L in NS and NS-RL group, respectively, be-
fore RT. Baseline K was 4.28 ± 0.70 mEq/L in the NS group
and 4.13±0.42 mEq/L in the NS-RL group. Baseline ABG test
measurements are indicated in Table 1.
4.2. Outcome Measures
Table 2 demonstrated the course of BUN and Cr
changes after RT. As it is shown, BUN was decreased in
the patients receiving NS in a 3-day assessment after RT
reached to 27.63 mg/dL, meanwhile, in patients in the other
group who received NS-RL solution, BUN was increased to
51.22 mg/dL. Evaluation of Cr revealed that in the NS group,
serum Cr was decreased throughout the study up to a 7-
day follow-up evaluation after the surgery, which reduced
to 1.49 mg/dL. Meanwhile, patients’ Cr in the NS-RL group,
after an incline in the period between before and after
surgery, was decreased to 2.95 mg/dL 7 days after RT. The
BUN and Cr levels were lower in the NS group compared to
the NS-RL group in all times evaluated after RT. These dif-
ferences were significant as it is shown in table 2 (P = 0.016,
0.005, and 0.002 after RT and 3 and 7 days after the opera-
tion for BUN, and P = 0.005, 0.001 and 0.001 after RT and 3
and 7 days after the operation for Cr).
The evaluation of serum Na and K is indicated in Ta-
ble 3. Serum K was increased in both groups after the
transplantation, but it was significantly lower in the NS
Table 1. Baseline Participants’ Characteristics
Characteristic NS NS-RL P Value
No. 23 23
Age, y, mean (SD) 44.52 (12.58) 45.43 (14.29) 0.750
Sex, No (%)
Female - 17 (37) 11 (47.8) 6 (26.1) 0.127
Male - 29 (63) 12 (52.2) 17 (73.9)
BUN, mg/dL, mean (SD) 39.22 (29.74) 29.74 (11.31) 0.878
Creatinine, mg/dL, Mean (SD) 6.90 (3.73) 6.25 (2.07) 0.912
Na, mEq/L, mean (SD) 139.17 (2.77) 137.22 (3.15) 0.080
K, mEq/L, mean (SD) 4.28 (0.70) 4.13 (0.42) 0.375
ABG, mean (SD)
pH 7.32 (0.08) 7.30 (0.09) 0.299
pCO2 , mmHg 33.96 (8.80) 32.26 (8.61) 0.513
HCO3 , mEq/L 18.55 (6.56) 16.36 (5.87) 0.239
BEesf , mEq/L -8.31 (5.38) -9.30 (7.09) 0.596
BE, mEq/L -7.60 (4.88) -9.39 (6.42) 0.293
Abbreviations: ABG, arterial blood gas test; BE, base excess; BEesf , base excess of
the extracellular fluid; BUN, blood urea nitrogen; HCO3 , bicarbonate; K, potas-
sium; Na, sodium; NS, normal saline; pCO2 : partial pressure of carbon dioxide;
RL, Ringer’s lactate.
Table 2. Analysis of BUN and Cr Before and After Transplantation in the NS and NS-RL
Groups
Time of Evaluation NS NS-RL P
Value
BUN, mean (SD), mg/dL
Before transplantation 39.22 (29.74) 29.74 (11.31) 0.878
After transplantation 30.57 (11.61) 39.48 (12.51) 0.016
3 days after
transplantation
27.63 (15.52) 51.22 (30.01) 0.005
7 days after
transplantation
27.91 (11.16) 50.30 (28.87) 0.002
Creatinine, mean (SD), mg/dL
Before transplantation 6.90 (3.73) 6.25 (2.07) 0.912
After transplantation 5.00 (1.65) 6.66 (2.08) 0.005
3 days after
transplantation
2.04 (1.66) 4.34 (3.17) 0.001
7 days after
transplantation
1.49 (1.00) 2.95 (2.28) 0.001
Abbreviations: BUN: blood urea nitrogen; NS, normal saline; RL, Ringer’s lac-
tate.
group compared with the NS-RL group (4.31 mEq/L versus
4.87 mEq/L, P = 0.028). Serum Na was decreased in the
NS-RL group, reaching to 136.78 mEq/L after RT, but this
electrolyte was increased to 139.48 mEq/L in the NS group.
Therefore, serum Na was lower in the NS-RL group after
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surgery which was statistically significant (P = 0.004). Pa-
tients’ arterial blood was evaluated with ABG test. There
were no significant differences between the two groups
regarding acid-base balance and other ABG measures, all
with P > 0.005 (Table 3). Neither case of hyperkalemia
nor acidosis was observed in evaluating the post-operative
blood samples.
5. Discussion
The aim of this study was to compare the effect of two
different crystalloid IV fluid solutions on ESRD patients’
renal function and acid-base and electrolyte balance after
living donor RT. This was the first study to evaluate the
normal saline-ringer’s lactate solution as the choice of IV
fluid infusion. In this study, the patients who received
normal saline during the operation had lower BUN and
Cr, which was preserved up to 7 days after the transplan-
tation. Comparing patients’ arterial blood after RT, Na
and K change levels were contradictory. Such that lower
mean Na level and higher mean K level were observed in








Na, mEq/L, mean (SD)
NS 139.17 (2.77) 139.48 (3.45) 0.004
NS-RL 137.22 (3.15) 136.78 (2.56)
K, mEq/L, mean (SD)
NS 4.28 (0.70) 4.31 (0.80) 0.028
NS-RL 4.13 (0.42) 4.87 (0.91)
ABG, mean (SD)
pH
NS 7.32 (0.08) 7.28 (0.09) 0.289
NS-RL 7.30 (0.09) 7.26 (0.07)
pCO2 , mmHg
NS 33.96 (8.80) 35.91 (7.49) 0.320
NS-RL 32.26 (8.61) 33.96 (5.54)
HCO3 , mEq/L
NS 18.55 (6.56) 15.77 (3.91) 0.583
NS-RL 16.36 (5.87) 15.18 (3.26)
BE, mEq/L
NS -9.60 (4.88) -9.91 (4.34) 0.516
NS-RL -9.39 (6.42) -9.79 (7.13)
Abbreviations: ABG, arterial blood gas test; BE, base excess; NS, normal saline;
HCO3: bicarbonate; K: potassium; Na, sodium; pCO2 : partial pressure of carbon
dioxide; RL: Ringer’s lactate.
the patients receiving NS-RL. Despite these differences, Na
and K levels were in the normal range in both groups and
hyperkalemia was observed in the patients receiving nei-
ther NS nor NS-RL during RT. Regarding changes in ABG, in
both study groups, a decrease in pH and bicarbonate lev-
els and an increase in pCO2 were noted. Even though these
changes were slightly higher in the NS group, there was no
difference between the two groups and acidosis was not
observed in both groups.
The NS is the first choice for IV fluid infusion during RT,
but various crystalloid solutions were studied with differ-
ent impact on electrolyte and acid-base balance (12). The
reason behind the selection of NS as the choice of fluid
therapy in ESRD patients during transplantation is to avoid
theoretical hyperkalemia caused by potassium-containing
crystalloids such as RL (12, 17). However, there is an ongo-
ing concern that the administration of a large amount of
NS could lead to metabolic acidosis due to dilutional aci-
dosis or hyperchloremic acidosis (18, 19). Regardless of its
reason, the acidosis may be of particular significance in pa-
tients with ESRD undergoing RT (9). Several studies sup-
ported the hypothesis that NS administration is associated
with metabolic acidosis compared to other balanced crys-
talloids such as RL and plasmalyte (5, 7, 9, 10). In Kim et al.
study (5), NS infusion was associated with lower pH and BE,
and patients receiving NS during living donor RT showed
hyperchloremic rather than dilutional metabolic acidosis.
In O’Malley et al. study (9), 31% of enrolled patients in
the NS group experienced metabolic acidosis compared to
zero patients in the RL group (P = 0.004) and suggested
that RL was associated with less acidosis. In a meta-analysis
by Trujillo-Zea et al. (10), the pH was lower in the NS group
(MD: 0.06; CI 95%: 0.05 - 0.08; P < 0.001; I2 = 17%) and it was
suggested that the NS causes metabolic acidosis, probably
as a result of hyperchloremia. In a Cochrane review con-
ducted by Wan et al. (20), the authors suggested that bal-
anced electrolyte solutions are associated with less hyper-
chloremic metabolic acidosis compared to NS; however, it
remains uncertain whether lower-chloride solutions lead
to improved graft outcomes compared to normal saline.
In Hadimioglu et al. (3) and Kanithi et al. (16) studies,
there was a significant decrease in pH, bicarbonate (HCO3),
and BE in NS group compared to RL and plasmalyte, re-
spectively, but no patient developed clinically significant
metabolic acidosis. In the present study, patient in nei-
ther group developed metabolic acidosis and there was no
significant difference between the NS and NS-RL regarding
pH, HCO3, and BE. This could be due to the use of the NS so-
lution in both groups and its effect on acid-base balance.
Hyperkalemia is an important aspect of managing pa-
tients undergoing RT. This phenomenon is expected with
the RL infusion. An extracellular shift of potassium caused
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by acute changes in blood hydrogen concentration after
NS administration could be a theoretical mechanism for
the development of hyperkalemia, which is related to hy-
perchloremic metabolic acidosis (11). In our study, al-
though serum K level was higher in the NS-RL group, there
was no incidence of hyperkalemia (defined as serum K >
5.9 mEq/L). Similar to our study, Hadimioglu et al. (3) re-
ported no significant changes of K levels in neither NS,
RL nor plasmalyte groups. In O’Malley et al. study (9),
19% of patients in the NS group versus zero patients in
the RL group had K concentrations > 6 mEq/L (P = 0.05).
In Trujillo-Zea et al. study (10), K differences was not sig-
nificant (means difference (MD: -0.26 mEq/L; CI 95%: -0.58
to 0.05 P = 0.10; I2 = 75%) between the NS and RL groups.
Gonzalez-Castro et al. (8) concluded that the use of bal-
anced crystalloids containing K in the perioperative period
of RT does not affect serum K levels more than NS. The dif-
ference in the K level in different studies could be due to dif-
ferences in the surgery duration and volume of fluid taken.
It seemed that a shorter duration of surgery and lower to-
tal volume of fluids infused is responsible for a lower inci-
dence of hyperkalemia.
Evaluation of day 3 and 7 BUN and Cr demonstrated
the higher renal function in patients receiving NS. Com-
paring NS and RL in Trujillo-Zea et al. meta-analysis (10),
no difference was reported in Cr level on the third post-
operative day (MD: -0.05; CI 95%: -0.59 to 0.48; P = 0.85; I2
= 0%). In Modi et al. study (4), 24 hours after the surgery,
serum creatinine was 2.43 ± 0.87 mg/dL in the RL group
compared to 2.82 ± 0.75 mg/dL in the NS group. Mean Cr
level on the day 3 of surgery in the Khajavi et al. study (15)
was 1.9 ± 0.7 mg/dL in the NS group and 2.2 ± 2.2 mg/dL in
the RL group (P = 0.425). In several studies, plasmalyte use
was associated with the best renal function (2, 6). Adwaney
et al. (2) reported better graft function at 3 months post-
operatively (estimated glomerular filtration rate 51 versus
44 mL/min/1.73 m2; P = 0.03) in patients receiving exclu-
sively plasmalyte compared to NS such that no difference
was seen in graft function at 1-year comparison. In Wein-
berg et al. study (6), the more Cr reduction was observed
in subjects receiving plasmalyte who did not require dial-
ysis compared to patients receiving NS 48 hours after the
surgery (-0.03 (-0.17, 0.10) compared to 0.18 (0.03, 0.34); P =
0.04).
Despite the strength of the present study, which is the
first to evaluate the effect of NS-RL solution, it is subjected
to a number of limitations. The first was the small sample
size and limited follow-up period (7 days). Cadaveric donor
renal recipients were excluded from the study while live
donor RTs make up 43% of transplantation annually in the
United States (21). Important factors such as the duration
of surgery and total fluid volume were not recorded, which
may influence the outcome, especially serum K level.
5.1. Conclusions
Our study showed that neither of NS or RL-NS solutions
were associated with the risk of hyperkalemia or acidosis
after RT; however, renal function was superior in patients
receiving NS infusion. Though there is no risk of hyper-
kalemia or acid-base imbalance with NS-RL solution, NS is
the IV fluid choice in RT due to the better renal function
profile.
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